Target
Clostridium difficile enterotoxin B
Description
Anti-Clostridium difficile enterotoxin B Antibody, Non-Fucosylated (BioBet-043ZP) is a human monoclonal IgG1 antibody against Clostridium difficile enterotoxin B. This product is an ADCC enhanced antibody produced by our Afuco™ platform.
Antibody Indication
Prevention of Clostridium difficile infection recurrence
Classification
Therapeutic antibody; biobetter
Cooperation Seeking
Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Clostridium difficile enterotoxin B antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Clone
BioBet-043ZP
Species Reactivity
C. difficile
Description
Bezlotoxumab, trade name Zinnlava, is a fully human monoclonal antibody that binds C. difficile toxin B and is designed to prevent the recurrence of C. difficile infection.
Antibody Indication
Clostridium difficile infection recurrence
